Neuroscience
Gray Matter Volume
100%
Functional Magnetic Resonance Imaging
61%
Tetrahydrocannabinol
57%
Gray Matter
55%
Magnetic Resonance Imaging
50%
Meta-Analysis
47%
Cannabidiol
45%
Working Memory
44%
Antipsychotic
41%
Negative Syndrome
33%
Voxel-Based Morphometry
33%
Cannabis
32%
Neuroscience
32%
Placebo
31%
Early Psychosis
27%
Positive Syndrome
25%
Longitudinal Study
24%
Mental Disorder
24%
Antidepressant
24%
Brain Function
23%
Inferior Frontal Gyrus
22%
Frontal Lobe
20%
Magnetic Resonance Imaging
19%
Anterior Cingulate Cortex
19%
Cognitive Disorders
18%
Relapsing Remitting Multiple Sclerosis
18%
Support Vector Machine
18%
Electroencephalogram
17%
Face
17%
Heroin
16%
Multiple Sclerosis
16%
Structural Magnetic Resonance Imaging
15%
Superior Frontal Gyrus
12%
Bipolar Disorder
12%
Prefrontal Cortex
11%
Cannabis Sativa
11%
Brain Activation
11%
Functional Connectivity
11%
Psychiatry
11%
Depressive Disorder
11%
Amygdala
10%
Neurotransmitter
10%
Brain Abnormalities
10%
Ventral Striatum
10%
Behavior (Neuroscience)
10%
Cingulate Cortex
9%
Precuneus
9%
Temporal Lobe
8%
Cerebellum
8%
Disorientation
8%
Psychology
Systematic Review
40%
Meta-Analysis
34%
Psychotic Disorder
31%
Mental State
26%
Schizophrenia
23%
Magnetic Resonance Imaging
21%
Functional Magnetic Resonance Imaging
20%
Neuroimaging
18%
Mental Health
16%
Psychometrics
12%
Resting-State
8%
Disorientation
8%
Publication Bias
8%
Social Emotion
8%
Negative Affect
8%
Polynomial Regression
8%
Human Brain
8%
Response Latency
8%
Validation Study
8%
Life Event
8%
Mood
8%
Second Life
8%
Structural Magnetic Resonance Imaging
8%
Neural Substrate
8%
Quality of Life
8%
Longitudinal Analysis
8%
Emotion Processing
8%
Oxytocin
8%
World Health Organization
8%
Cognitive Impairment
8%
Social Interaction
8%
High-Risk Population
8%
Depressive Disorder
6%
Working Memory
6%
Functional Connectivity
6%
Neuroimaging Study
5%
Regression Model
5%
Exploratory Factor Analysis
5%
Factor Analysis
5%
Medicine and Dentistry
At Risk Mental State
17%
Prodrome
16%
Systematic Review
16%
Tetrahydrocannabinol
16%
Meta-Analysis
14%
Cannabidiol
13%
Volunteer
13%
Biological Marker
12%
Magnetic Resonance Imaging
10%
Early Psychosis
10%
Negative Syndrome
10%
High Risk Population
9%
Lifespan
9%
Dronabinol
9%
Structural Magnetic Resonance Imaging
8%
Morphometrics
8%
COVID-19
8%
Mental Health
8%
Multimodal Imaging
8%
Effects of Cannabis
8%
Infection
8%
Voxel-Based Morphometry
8%
Clinical Psychiatry
8%
Mental Disorder
8%
Anticipation
8%
Chlordiazepoxide
8%
Nervous System Disorder
8%
Clinician
8%
Proteomics
8%
Placebo
7%
Verbal Learning
6%
Functional Magnetic Resonance Imaging
5%
Population Risk
5%
Quality of Life
5%
Depressive Disorder
5%
Diseases
5%
